EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Overlapping roles of dysregulated glycolysis in the pathophysiology of diabetes and cancer

Nicola Marrano iD, Angela Cappello, Giuseppina Biondi iD, Carlo Ganini, Antonella Cormio, Angelo Cignarelli iD, Sebastio Perrini iD, Luigi Laviola iD, Camillo Porta iD, Francesco Giorgino iD, Annalisa Natalicchio iD

Endocrine Reviews · 28.10.2026

DOI: 10.1210/endrev/bnag043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine Reviews, online erschienen am 28.10.2026. Verfasst von Nicola Marrano und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Precision and Regenerative Medicine and Ionian Area, University of Bari Aldo Moro, Bari, Italy. Die Arbeit nennt 257 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, Updated Bioresearch on Uncured Neuroendocrine Neoplasms for New Therapies and Unexpected Response Rates.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Emerging evidence highlights a strong association between type 2 diabetes (T2D) and increased cancer risk, with partially overlapping metabolic disruptions potentially driving both diseases. Chronic hyperglycemia, a hallmark of T2D, disrupts glycolytic flux and contributes to the accumulation of toxic intermediates, driving cellular damage and diabetic complications. Specifically, dysregulation of glycolytic enzymes diverts metabolites into harmful pathways, promoting oxidative and glycative stress across multiple cell types. Similar metabolic disturbances support cancer development and progression by fueling rapid tumor cell proliferation. This review explores the role of abnormal glycolysis as a potential mechanistic link between T2D and cancer, detailing shared enzymatic alterations and metabolic pathway shifts. Additionally, it discusses pharmacological therapeutic strategies targeting glycolysis-related abnormalities common to both diseases, emphasizing the need for balanced metabolic modulation.

Schlagwörter

Stichwörter der Autor:innen

Diabetescancerdiabetic complicationsglycolysisglycolytic intermediates

Autor:innen und Institutionen

  • Department of Precision and Regenerative Medicine and Ionian Area, University of Bari Aldo Moro, Bari, Italy.
  • Division of Medical Oncology, A.O.U. Consorziale Policlinico di Bari, Bari, Italy.
  • Interdisciplinary Department of Medicine, Division of Medical Oncology, University of Bari Aldo Moro, Bari, Italy.
  • Department of Medicine and Surgery, Section of Endocrinology, LUM University, Casamassima, Bari, Italy.

ORCID-Profile: Nicola Marrano, Giuseppina Biondi, Angelo Cignarelli, Sebastio Perrini, Luigi Laviola, Camillo Porta, Francesco Giorgino, Annalisa Natalicchio

Förderung

  • Ministero della Salute
  • Updated Bioresearch on Uncured Neuroendocrine Neoplasms for New Therapies and Unexpected Response Rates

Zitieren

APA

Marrano, N., Cappello, A., Biondi, G., Ganini, C., Cormio, A., Cignarelli, A., Perrini, S., Laviola, L., Porta, C., Giorgino, F., & Natalicchio, A. (2026). Overlapping roles of dysregulated glycolysis in the pathophysiology of diabetes and cancer. Endocrine Reviews. https://doi.org/10.1210/endrev/bnag043

Vancouver

Marrano N, Cappello A, Biondi G, Ganini C, Cormio A, Cignarelli A, et al. Overlapping roles of dysregulated glycolysis in the pathophysiology of diabetes and cancer. Endocrine Reviews. 2026. doi:10.1210/endrev/bnag043

BibTeX
@article{Marrano2026,
  author = {Marrano, Nicola and Cappello, Angela and Biondi, Giuseppina and Ganini, Carlo and Cormio, Antonella and Cignarelli, Angelo and Perrini, Sebastio and Laviola, Luigi and Porta, Camillo and Giorgino, Francesco and Natalicchio, Annalisa},
  title = {Overlapping roles of dysregulated glycolysis in the pathophysiology of diabetes and cancer},
  journal = {Endocrine Reviews},
  year = {2026},
  doi = {10.1210/endrev/bnag043}
}
Kostenlos starten →